Apimeds Pharmaceuticals US, Inc.
APUS
$1.63
-$0.15-8.43%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.81% | -99.15% | -96.46% | -- | 2,277.42% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.80% | -17.24% | -94.00% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 64.81% | -96.90% | -96.00% | -- | -- |
|
|
|||||
| Total Current Assets | 64.81% | -96.90% | -96.00% | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 64.81% | -96.90% | -96.00% | -- | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 677.20% | 465.94% | 740.99% | -- | -- |
| Short-term Debt | -- | -- | -20.63% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1,197.00% | 730.74% | 101.91% | -- | -- |
|
|
|||||
| Total Current Liabilities | 1,197.00% | 730.74% | 101.91% | -- | -- |
| Long-Term Debt | -12.53% | 29.94% | -19.50% | -- | -- |
| Short-term Debt | -- | -- | -20.63% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 378.43% | 251.41% | 39.42% | -- | -- |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 45.81% | -- | -- |
| Retained Earnings | -45.35% | -46.30% | -67.57% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -565.34% | -4,357.37% | -818.26% | -- | 62.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -565.34% | -4,357.37% | -818.26% | -- | 62.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -565.34% | -4,357.37% | -818.26% | -- | 62.92% |
|
|
|||||